Pharmacokinetics of pantoprazole in man.

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Pharmacokinetics of pantoprazole in man.

International journal of clinical pharmacology and therapeutics - 1 May 1996

Huber R, Hartmann M, Bliesath H, Lühmann R, Steinijans V W, Zech K

Abstract excerpt

The proton pump inhibitor pantoprazole is a substituted benzimidazole sulphoxide for the treatment of acid-related gastrointestinal diseases such as reflux esophagitis, duodenal and gastric ulcers. Pantoprazole, administered as a 40 mg enteric coated tablet, is quantitatively absorbed. Its absolu...

Topics

2-Pyridinylmethylsulfinylbenzimidazoles
Administration, Oral
Adolescent
Adult
Aged
Anti-Ulcer Agents
Benzimidazoles
Biological Availability
Chromatography, High Pressure Liquid
Female
Half-Life
Humans
Injections, Intravenous
Kidney Diseases
Liver Cirrhosis
Male
Middle Aged
Omeprazole

Source

Open in PubMed

Identifiers

PMID: 8738854

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-8738854-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics